Agenda
Day 1 — Main Conference
October 16, 2023

David BidermanPartner
Firmwide Chair, Consumer Products & Services LitigationPerkins Coie LLP

Lori LeskinPartner
Co-Chair, Consumer Products Practice GroupArnold & Porter Kaye Scholer LLP
Cross-Industry Class Action Roundup: Examining the Latest Class Action Trends in Food, Cosmetics and Dietary Supplements

Sabrina MizrachiVP, Litigation & Global Product RegulatoryEstée Lauder Companies

Christine McInerneyHead of LitigationNestle Health Science

Amanda WeinbergerSenior CounselSara Lee Frozen Bakery

Mark Brian LevineAssociate General CounselReckitt Benckiser

Ani GulatiChief Litigation CounselGeneral Mills

David BidermanPartner
Firmwide Chair, Consumer Products & Services LitigationPerkins Coie LLP
In our morning roundup, leading in-house counsel from the food, cosmetic, and dietary supplements industries will provide an analysis of the latest class action activity targeting their respective industries. Topics of discussion will include:
- The latest advertising and labeling practices which are triggering class action claims
- Healthy
- Natural
- Sustainable
- Health claims vs. structure function
- Key lessons and takeaways from the latest class litigations
- Insights on where the next class action hot spots may occur
- Supplements and illegal drug claims, Li et al v. Amazon (N.D. Cal. 2023)
- Predicting when you may be a class action target
Exploring How New Legislation and Agency Guidance Will Impact Future Class Action Litigation Involving FDA Consumer Products

Megan OlsenSenior Vice President & General CounselCouncil for Responsible Nutrition

Joseph ConklinSVP & Global Deputy General CounselCoty Inc.

Joseph AquilinaSr. Director, Associate General CounselConsumer Brands Association
- Assessing the impact of new cosmetic regulatory reform: how will the Modernization of Cosmetics Regulation Act of 2022 (MOCRA) impact the industry and future litigation?
- Examining the FTC’s recent revisions to dietary supplement advertising guidelines: how does this expand or reinforce FTC’s authority and what are the potential implications on future claims?
- Exploring the potential impact of FDA’s new proposed rule updating the criteria for making “healthy” claims on food labels
- Understanding how potential FTC updates to the Green Guides for the Use of Environmental Claims may impact future claims across the food, cosmetic and supplements industry
Morning Coffee Break
A Cross-Circuit Analysis of Recent Class Certification Developments in Food, Cosmetics and Supplements Class Actions

Lori LeskinPartner
Co-Chair, Consumer Products Practice GroupArnold & Porter Kaye Scholer LLP

Thomas SullivanPartnerShook Hardy & Bacon LLP

Sylvia SimsonShareholder Greenberg Traurig LLP
- Assessing the latest class certification rulings and trends across key circuits relating to food, cosmetics and supplements
- What plaintiff strategies are winning the day in certifying classes in FDA-regulated consumer product cases?
- Identifying defense challenges to class certification that are seeing the most success in these industries

Matthew OrrPartnerAmin Talati Wasserman LLP
Class actions lawsuits affecting food cosmetics, and supplements usually begin with a demand letter. This session will provide a look at recent demand letter trends affecting these industries and strategies to employ for when one arrives on your desk.
- Examining demand letter trends in these FDA-Consumer industries
- Recent labeling and marketing triggers
- State consumer protection law violations
- Developing internal protocols to address demand letters
- Evaluating the class action probability from the letter
- What can we glean about the potential of the case from the law firm/attorney who sent the letter?
- Understanding when and how to enlist outside counsel
- Weighing the risk of responding vs. not responding while being mindful of the response deadline
- Identifying who else may have received the same demand letter and how this should factor into your decision
- Understanding how to make the “fish or cut bait” decision
- Which actions are worth fighting and which should be settled right away?
- Grasping what types of cases settle, which don’t, and how much should be paid
- Identifying claims that never win, e.g., FDC&A defeat
Networking Luncheon
Contamination Class Actions
Contaminant Class Actions: What Every Defense Attorney for an FDA-Regulated Consumer Industry Needs to Know About PFAS, Heavy Metals, and Titanium Dioxide

Dale GialiPartnerKing & Spalding LLP

Aliza R. KaretnickPartnerBallard Spahr LLP
Contaminants such as PFAS – forever chemicals, heavy metals, and other trace substances are spawning a new breed of highly aggressive class action litigation. They are affecting almost every industry but are of particular concern to the FDA-regulated consumer goods sector. What’s more, the plaintiffs’ bar has begun bringing putative class actions alleging that the presence of Titanium Dioxide makes consumer products unsafe. This panel will examine recent contaminant class actions affecting these industries and provide insights on what to do if your company is hit with one of these lawsuits. This panel will examine:
PFAS, Heavy Metals & Other Trace Chemicals
- Understanding the legal nuances of contaminant litigations – How are these lawsuits different from other class action claims?
- What theories are plaintiffs relying on in these claims, and what defense strategies are proving to withstand the latest plaintiff challenges?
- Examining how product testing/sourcing and recorded regulatory approval can yield additional strategies for class-action defense of PFAS and other related trace chemical lawsuits
Spotlight on Titanium Dioxide: The Latest Target in FDA-Regulated Consumer Product Class-Action Lawsuits
- Examining the rising trend of Titanium Dioxide class actions being brought across the food, cosmetic and supplements industry
- Common themes, allegations and takeaways
- How companies and their counsel should be reviewing product formulations and label claims to mitigate litigation risks associated with the presence of TiO2
Afternoon Break
Understanding How Prop 65 Activity is Influencing Class Actions Against FDA-Regulated Consumer Product Companies

Amy LallyPartnerSidley Austin LLP

Rohit SabnisPartnerKeller & Heckman
- Examining the latest trends in Prop 65 activity that the food, cosmetic and dietary supplements industries should be paying attention to
- Understanding how the Prop 65 acrylamide ruling may have ended class actions against food companies in this category
- Examining the new dark chocolate class actions and their similarity to Prop 65 actions
Tactical Tools for Class Action Prevention: How Proper Claims Substantiation and Sound Labeling Practices Are Sometimes Your Best Offense

Abby MeyerPartnerSheppard, Mullin, Richter & Hampton LLP

John W.M. ClaudCounselHyman, Phelps & McNamara, P.C.
- Examining claims language, advertising methods and other actions a company can take to reduce the risk of a class action
- Understanding how proper and compliant labeling can defeat a class
- FDC&A compliance
- Being proactive in substantiating marketing and labeling claims with competent and reliable scientific evidence
Conference Adjourns
Day 2 — Main Conference
October 17, 2023
Co-Chairs’ Welcome Back and Recap of Day 1
Understanding How Consumer Protection Groups, and the Plaintiff’s Bar Are Working in Tandem to Police Claims, Labeling, and Other Marketing Practices Leading to Class Actions

Thomas A. EvansPartnerAlston & Bird

Amy MudgePartner and Chair Advertising, Marketing and Digital Media TeamBaker & Hostetler LLP

Claudia LewisPartnerVenable
- How is the plaintiff’s bar targeting labeling practices governed by the FDCA and other statutes that do not include a private right of action?
- Understanding the role that consumer protection groups (and third parties that hold themselves out as consumer protection organizations) play in policing claims and labeling practices that springboard into class actions
- Assessing the DC Consumer Protection Procedures Act and precedent allowing third-party consumer protection groups the right to sue for allegedly false or misleading claims
- How can companies defend against third-party lawsuits and reduce the risk of these lawsuits?
- Understanding how industry can work with regulators and consumer protection groups to ensure proper claims and self-police thereby avoiding class actions
- Examining the plaintiff’s bar’s recent attempts to police claims and labeling like government regulators through recent class action activity
Addressing the Role of Flawed Science in Driving Mass Litigation in the Food, Cosmetic and Supplements Industries

Risa DrexlerAssociate General Counsel – Global LitigationNutrition North America, Unilever

Chris LiwskiHead of Legal North America and Global Head of LitigationSanofi Consumer Healthcare

Patrick OotPartnerShook, Hardy & Bacon LLP

Julie L. TersigniSenior Counsel, Products LiabilityKenvue
Testing labs have recently filed citizen petitions with the FDA in attempts to provide support for economic loss class actions and personal injury mass tort litigation in the consumer products space. This panel will address the rising role of independent laboratories spawning FDA consumer product class actions, and examine topics including:
- What types of products are they targeting for independent testing?
- What should consumer product companies be doing to stay out of their spotlight?
- Crafting successful challenges to the legitimacy of the independent testing of these groups and the science behind their studies
- How to educate the court about the junk science that FRE 702 is designed to protect against
Morning Coffee Break

Kristine ArgentinePartnerSeyfarth Shaw LLP

Jonah KnoblerPartnerPatterson Belknap Webb & Tyler LLP
- Identifying primary jurisdiction and standing arguments which may be effective in eliminating or narrowing a class at the motion to dismiss stage
- Understanding the primary jurisdiction challenges which are most prevalent in FDA-regulated consumer product class actions, as well as how to manage and overcome them
- Navigating standing in the aftermath of TransUnion LLC v. Ramirez: incorporating takeaways from the latest court rulings into your class action litigation practices and strategies
A New Look at Preemption: Recent Developments Impacting How Food, Cosmetic and Supplement Defendants May Rely on this Defense in Future Class Actions

Jessica DavidsonPartnerSkadden, Arps, Slate, Meagher & Flom LLP
- Examining the impact of MoCRA on future class action preemption defenses, particularly with regard to PFAS
- Assessing how FDA’s recent guidance (e.g. guidance for determining and declaring the protein grams in a serving) has helped to provide preemption defenses to false advertising in the food, cosmetic, as supplement space
- Analyzing recent case law developments impacting express and implied preemption and how this may be useful to FDA-regulated consumer goods companies
- Truss v. Bayer Healthcare Pharmaceuticals Inc.
- Nexus Pharmaceuticals Inc. v. Central Admixture Pharmacy
Networking Luncheon

Jason MeltzerPartnerGibson, Dunn & Crutcher LLP

Jason StiehlPartnerCrowell & Moring LLP
- Examining creative plaintiffs’ bar tactics being used in these types of class actions as well as winning defense strategies to combat them
- Identifying new types of causes of actions being brought: what do current trends in class claims predict about potential future class action activity?
- Exploring examples where plaintiff’s counsel has been successful in defeating preemption defenses
- In light of new developments in preemption, predicting how plaintiff’s bar tactics may change going forward

Kimberly BousquetCounselDavis Wright Tremaine LLP

Hih Song KimExecutive Vice President, General Counsel and CorporateBlueTriton Brands
- Identifying common challenges arising in FDA consumer product class settlements as well as key strategies for tackling those challenges
- Comparing class settlement trends by jurisdiction
- Identifying favorable jurisdictions to settle in, as well as jurisdictions to avoid settlement in
- Proven defense strategies for drafting settlement agreements, structuring the settlement benefit and noticing the class
- Best practices for dealing with more than one judge when a class action is filed in multiple jurisdictions
- Working with a settlement administrator to ensure the settlement is implemented with efficiency and accuracy
- Understanding how to make the decision of whether to settle or go to trial
- Structuring your settlement agreement so you don’t leave yourself exposed to future lawsuits
Afternoon Break

Trenton NorrisPartnerHogan Lovells

Lori LeskinPartner
Co-Chair, Consumer Products Practice GroupArnold & Porter Kaye Scholer LLP
This hands-on session will test your litigation savvy through a series of complex, hypothetical scenarios which may arise in an FDA-regulated consumer product class action. Using audience polling, you will discover how your approach to mounting and tackling a class action defense compares to your peers. Benefit from a practical discussion of the polling results and walk away with winning strategies for all phases of a class action litigation, including:
- Designing thorough internal class action preparedness protocols
- Forging pre-suit defense strategies
- Establishing document hold and retention policies
- Pre-suit demand letter protocols
- Considerations for budgeting and forecasting of litigation costs
- Building joint litigation agreements
- Class formation challenges
- Discovery challenges
- Knowing when going to trial is the right thing to do
- Understanding when settlement is your best option